biote Corp.

NASDAQ: BTMD · Real-Time Price · USD
3.33
-0.21 (-5.93%)
At close: Apr 30, 2025, 3:59 PM
3.33
0.00%
After-hours: Apr 30, 2025, 04:22 PM EDT

Company Description

biote Corp. operates in medical practice-building business within the hormone optimization space.

The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements.

It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women.

The company was founded in 2011 and is headquartered in Irvine, Texas.

biote Corp.
biote Corp. logo
Country United States
IPO Date Apr 28, 2021
Industry Medical - Care Facilities
Sector Healthcare
Employees 217
CEO Bret Christensen

Contact Details

Address:
1875 West Walnut Hill Lane
Irving, Texas
United States
Website https://biote.com

Stock Details

Ticker Symbol BTMD
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001819253
CUSIP Number 090683103
ISIN Number US0906831039
Employer ID 85-1791125
SIC Code 2833

Key Executives

Name Position
Bret Christensen Chief Executive Officer & Director
James Elliott Gibbs II Chief People Officer
Joel Pickering Chief Marketing Officer
John J. Olsen Chief Information Officer
Robert C. Peterson Chief Financial Officer
Dr. Cory Rice D.O. Chief Clinical Advisor & Member of Medical Advisory Board
Jade Beutler Head of Nutraceuticals
Marc D. Beer Executive Chairman
Mary Elizabeth Conlon Vice President of Business Development, General Counsel & Corporate Secretary
Richard Kevin Key Chief Digital Officer

Latest SEC Filings

Date Type Title
Apr 24, 2025 8-K Current Report
Apr 23, 2025 4 Filing
Apr 18, 2025 4 Filing
Apr 10, 2025 4 Filing
Apr 09, 2025 POS AM Filing
Apr 09, 2025 S-8 Filing
Apr 07, 2025 4 Filing
Apr 03, 2025 ARS Filing
Apr 03, 2025 DEFA14A Filing
Apr 03, 2025 DEF 14A Filing